BPA Call DOCSB134116BR0015-1333ND18FNB640222
- Not listed
- This is a firm fixed price BPA (Blanket Purchase Agreement) call order issued by the Department of the Interior US Geological Survey Office of Acquisitions and Grants to Illumina, Inc., a for-profit manufacturer of genomic sequencing instruments and reagents. The $4,257.76 order provides Illumina products and services to support the agency's genomic analysis work, likely across its various scientific research programs. Illumina has previously been awarded prime federal contracts by agencies such...
- This is a firm fixed-price Blanket Purchase Agreement (BPA) call order awarded by the National Institute of Standards and Technology (NIST), a civilian agency, to Illumina, Inc. for the purchase of Illumina consumables. The award has a ceiling value of $14,830.40 and a completion date of September 1, 2017. Illumina is a manufacturer and provider of genomic sequencing and analysis instruments and reagents, and has received numerous past contract and sub-contract awards from government agencies...
- This is a firm fixed price contract awarded by the Northeast Area of the U.S. federal agency to Illumina, Inc. for a $29,070.00 Blanket Purchase Agreement (BPA) call to provide a comprehensive support plan for Illumina's NextSeq 500 sequencing system. The contract is not set aside and was awarded directly to Illumina as the prime contractor and manufacturer of the sequencing instruments. Illumina has a history of providing a range of sequencing instruments, reagents, and services to support...
- This is a firm fixed price Blanket Purchase Agreement (BPA) call awarded by the Northeast Area of a civilian federal agency to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The contract, valued at $11,132.37, is for the delivery of NextSeq and TruSeq sequencing supplies and consumables, including index plates, kits, and reagents. No set-aside designation was used. Illumina has a history of providing sequencing systems and related products to...
- This is a firm fixed price BPA call contract awarded by the Northeast Area of a civilian federal agency to Illumina, Inc., a manufacturer of genetic sequencing instruments and consumables. The contract, valued at $22,121.22, is for the provision of Illumina sequencing consumables and supplies. Illumina has previously received numerous prime federal contract and subcontract awards from agencies such as the National Institutes of Health, Centers for Disease Control and Prevention, Department of...
- This is a consumable supply order awarded to Illumina, Inc., a leading biotechnology company specializing in genetic sequencing and genomic analysis technologies. The contract, issued on April 22, 2019, carries a ceiling value of $10,859.68 and is structured as a Blanket Purchase Agreement (BPA) call with firm fixed pricing. The award supports the Northeast Area civilian agency with a place of performance in Orient, New York, and does not utilize a set-aside designation, reflecting Illumina's...
- This is a firm fixed price delivery order awarded by the National Institute of Standards and Technology (NIST), a civilian agency, to Illumina, Inc. for the purchase of various Illumina reagents and consumables. The order has a ceiling value of $25,699.65 and a period of performance ending on March 31, 2017. This order is likely part of a larger Blanket Purchase Agreement (BPA) contract vehicle used by NIST to acquire Illumina sequencing products and services on an as-needed basis. Illumina is a...
- The U.S. government awarded a Blanket Purchase Agreement (BPA) call to Illumina, Inc. for the procurement of consumable supplies related to illumina sequencing technologies. The contract was awarded on February 14, 2019, with a ceiling value of $21,173.98 and an ultimate completion date of September 9, 2019. This firm fixed-price BPA call was issued under a civilian federal agency (Northeast Area) without set-aside designation, reflecting Illumina's specialized capabilities in genomic sequencing...
- This is a firm fixed price delivery order awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a civilian agency, to Illumina, Inc. The order is for $75,832.10 and does not have a set-aside designation. Illumina, a manufacturer of genetic sequencing instruments and consumables, is providing products and services to support genomic sequencing and analysis, including NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, reagents, and bioinformatics support....
- This is a firm fixed price BPA call issued by the Northeast Area division of a civilian federal agency, with a ceiling value of $15,500.16. The contract was awarded to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract provides for the delivery of Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, along with associated reagents, consumables, sample preparation kits, sequencing chips, support plans, maintenance...
- DOCSB134116BR0015Blanket Purchase Agreement
- DOCSB134116BR0015-1333ND18FNB640222BPA Call
This is a firm fixed price BPA call order issued by the National Institute of Standards and Technology, a civilian agency, to Illumina, Inc. for the provision of Illumina instrumentation, reagents, and consumables. The $29,277.19 order was placed against a previously established Blanket Purchase Agreement (BPA) contract, and there were no set-aside requirements. Illumina is a manufacturer and provider of sequencing and array-based solutions for genetic and genomic analysis, and has previously received prime federal contract and sub-contract awards from agencies such as the NIH, CDC, USDA, and VA to support genomic sequencing and analysis. This specific order is intended to provide various NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, accompanying reagents and consumables, sample prep kits, sequencing chips, support plans, maintenance services, and bioinformatics products to support the agency's work. Illumina also holds an Indefinite Delivery Contract with the Department of the Navy Bureau of Medicine and Surgery for nucleic acid sequencing needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P24001 | Funding Only Action | ($11k) | 6/24/24 | |
| Not listed | Not listed | $40.0k | 9/19/18 |